scorecardresearchSolara Active Pharma Sciences Share Price Live NSE, BSE, Today - Solara
Mintgenie
Asian Paints3,161.35-8.25 (-0.26%)
Axis Bank1,036.755.50 (0.53%)
Bajaj Finance7,809.4072.25 (0.93%)
Bajaj Finserve1,540.451.25 (0.08%)
Bharti Airtel927.302.25 (0.24%)
HCL Technologies1,236.20-6.95 (-0.56%)
HDFC Bank1,526.553.60 (0.24%)
Hindustan Unilever2,467.957.75 (0.32%)
ICICI Bank952.059.35 (0.99%)
ITC444.403.70 (0.84%)
Indusind Bank1,426.2012.80 (0.91%)
Infosys1,435.05-4.45 (-0.31%)
Kotak Mahindra Bank1,735.703.25 (0.19%)
Larsen & Toubro3,021.9510.10 (0.34%)
Mahindra & Mahindra1,553.65-3.05 (-0.20%)
Maruti Suzuki India10,570.353.40 (0.03%)
NTPC245.657.85 (3.30%)
Nestle India22,458.45-64.05 (-0.28%)
Power Grid Corporation Of India199.85-0.90 (-0.45%)
Reliance Industries2,346.5012.50 (0.54%)
State Bank Of India598.708.75 (1.48%)
Sun Pharmaceutical Industries1,159.1026.95 (2.38%)
Tata Consultancy Services3,530.75-6.50 (-0.18%)
Tata Motors630.3516.40 (2.67%)
Tata Steel129.002.25 (1.78%)
Tech Mahindra1,225.00-4.50 (-0.37%)
Titan Company3,149.60-10.95 (-0.35%)
Ultratech Cement8,260.00106.75 (1.31%)
Wipro406.250.45 (0.11%)

Solara Active Pharma Sciences

BSE: 541540 | NSE: SOLARA | ISIN: INE624Z01016 | SECTOR: Biotechnology & Drugs

₹357.20 4.65 (1.32%)

29 Sep 2023, 10:25 (IST)

  • Open

    352.85

  • High

    359.35

  • Low

    352.85

  • Prev Close

    352.55

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    12.86B

  • Volume

    7.78K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    357.20
View all metrics

Promoter Pledge Holding - 15.64%

Promoter NameNo of SharesPercentage
ARUNKUMAR PILLAI16,25,4634.52%
PADMAKUMAR KARUNAKARAN PILLAI25,0000.06%
CHAYADEEP VENTURES LLP8,62,4002.39%
PRONOMZ VENTURES LLP13,24,9103.68%
AGNUS CAPITAL LLP8,49,6352.36%
KARUNA BUSINESS SOLUTIONS LLP41,3700.11%
KARUNA VENTURES PRIVATE LIMITED1,03,3330.29%
AGNUS HOLDINGS PVT LTD2,72,1810.76%
CHAYADEEP PROPERTIES PVT LTD5,25,7301.46%

Company Description

  • Biotechnology & Drugs

  • BSE

    541540

  • NSE

    SOLARA

  • ISIN

    INE624Z01016

Solara Active Pharma Sciences Limited is an India-based company offering diversified, commercial active pharmaceutical ingredients (APIs) and contract manufacturing services in over 70 countries. The Company operates through the API segment. Its commercial and research and development products include Albendazole, Aprepitant (Antiemetic), Artesunate, Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Antitubercular), Ethacrynic Acid (Cardiovascular Agent), Hydralazine Hydrochloride (Anti-Hypertensive), Ibuprofen Sodium Dihydrate (Anti-inflammatory), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (OAB Treatment), Pentoxifylline, and others. The Company works with pharmaceutical companies from North America, Europe, and Japan.

Company Officers

  • Poorvank Purohit

    Chief Executive Officer, Managing Director, Director

  • M. Mohan

    Chief Operating Officer

  • Rajeev Singh

    Chief Human Resource Officer

  • Sudhir Nambiar

    Chief Scientific Officer (Head R&D)

  • S. Murali Krishna

    Compliance Officer, Company Secretary

  • V. Sundara Moorthy

    Chief Quality Officer